Compare Manggung Polahraya Tbk. (MANG) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Manggung Polahraya Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Manggung Polahraya Tbk. trades at Rp40 (market cap 152.5B, 21.81M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Manggung Polahraya Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| MANG | SCPI | |
|---|---|---|
Market Cap | 152.5B | 104.4B |
Volume | 21.81M | — |
Lot | 218.07K | — |
Turnover | 841.38M | — |
Average Price | 38.58 | — |
Value | 841.38M | — |
Indicative Equilibrium Price | 40 | — |
Indicative Equilibrium Volume | 472 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Manggung Polahraya Tbk.
PT Manggung Polahraya Tbk (Company) was established in Jakarta based on notarial deed No. 3 dated February 5, 1992, which was made by Esther Mercia Sulaiman, S.H., notary in Cianjur.
Read more on MANG →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
